Mechanistic aspects of mda-7/IL-24 cancer cell selectivity analysed via a bacterial fusion protein

Oncogene

Volumn 23, Issue 46, 2004, Pages 7679-7690

  Sauane, Moira ^a   Gopalkrishnan, Rahul V ^a   Choo, Heng Tong ^a   Gupta, Pankaj ^a   Lebedeva, Irina V ^a   Yacoub, Adly ^b   Dent, Paul ^b   Fisher, Paul B ^a  

^a College of Physicians and Surgeons ^*  (United States)

^b VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

Author keywords

Apoptosis; Breast cancer; Cancer gene therapy; GST MDA 7 IL 24; Radiotherapy

Indexed keywords

4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; ADENOVIRUS VECTOR; GST MDA 7 PROTEIN; HYBRID PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; RAS PROTEIN; STAT PROTEIN; STRESS ACTIVATED PROTEIN KINASE; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CANCER CELL; CELL KILLING; CELL SPECIFICITY; CONTROLLED STUDY; CYTOTOXICITY; DRUG SELECTIVITY; ENZYME ACTIVATION; FLUORESCENCE ACTIVATED CELL SORTING; GENE EXPRESSION; GENE LOCATION; GENE THERAPY; GOLGI COMPLEX; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN PURIFICATION; RADIOSENSITIZATION; RECEPTOR BINDING; SIGNAL TRANSDUCTION;

ANIMALS; APOPTOSIS; BREAST NEOPLASMS; CELL LINE, TUMOR; FEMALE; GENE THERAPY; GENES, TUMOR SUPPRESSOR; GLUTATHIONE TRANSFERASE; HUMANS; INTERLEUKINS; RECOMBINANT FUSION PROTEINS; SIGNAL TRANSDUCTION; TRANSPLANTATION, HETEROLOGOUS;

ADENOVIRIDAE; BACTERIA (MICROORGANISMS);

EID: 7044268950     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1207958     Document Type: Article

References (46)

1. Blaszkowsky L. (1998). Front. Biosci., 3, E214-E225.
2. Blumberg H, Conklin D, Xu WF, Grossmann A, Brender T, Carollo S, Eagan M, Foster D, Haldeman BA, Hammond A, Haugen H, Jelinek L, Kelly JD, Madden K, Maurer MF, Parrish-Novak J, Prunkard D, Sexson S, Sprecher C, Waggie K, West J, Whitmore TE, Yao L, Kuechle MK, Dale BA and Chandrasekher YA. (2001). Cell, 104, 9-19.
3. Caudell EG, Mumm JB, Poindexter N, Ekmekcioglu S, Mhashilkar AM, Yang XH, Retter MW, Hill P, Chada S and Grimm EA. (2002). J. Immunol., 168, 6041-6046.
4. Chada S, Nemunitais J, Tong AW, Zhang Y, Su D, Mhashilkar A, Yang H, Parker K, Wilson D, Merritt JA and Coffee K. (2001). Cancer Gene Ther., 8, S3.
5. Darnell Jr JE, Kerr IM and Stark GR. (1994). Science, 264, 1415-1421.
6. Fickenscher H, Hor S, Kupers H, Knappe A, Wittmann S and Sticht H. (2002). Trends Immunol., 23, 89-96.
7. Fisher PB, Gopalkrishnan RV, Chada S, Ramesh R, Grimm EA, Rosenfeld MR, Curiel DT and Dent P. (2003). Cancer Biol. Ther., 2, S23-S37.
8. Gallagher G, Dickensheets H, Eskdale J, Izotova LS, Mirochnitchenko OV, Peat JD, Vazquez N, Pestka S, Donnelly RP and Kotenko SV. (2000). Genes Immun., 1, 442-450.
9. Hilgers W and Kern SE. (1999). Genes Chromosomes Cancer, 26, 1-12.
10. Huang EY, Madireddi MT, Gopalkrishnan RV, Leszczyniecka M, Su Z, Lebedeva IV, Kang D, Jiang H, Lin JJ, Alexandre D, Chen Y, Vozhilla N, Mei MX, Christiansen KA, Sivo F, Goldstein NI, Mhashilkar AB, Chada S, Huberman E, Pestka S and Fisher PB. (2001). Oncogens, 20, 7051-7063.
11. Jiang H and Fisher PB. (1993). Mol. Cell. Diff., 1, 285-299.
12. Jiang H, Lin J, Su Z-Z and Fisher PB. (1996a). Mol. Cell. Diff., 1, 317-323.
13. Jiang H, Lin JJ, Su Z-Z, Goldstein NI and Fisher PB. (1995). Oncogene, 11, 2477-2486.
14. Jiang H, Su Z-Z, Lin JJ, Goldstein NI, Young CSH and Fisher PB. (1996b). Proc. Natl. Acad. Sci. USA, 93, 9160-9165.
15. Kisseleva T, Bhattacharya S, Braunstein J and Schindler CW. (2002). Gene, 285, 1-24.
16. Kotenko SV. (2002). Cytokine Growth Factor Rev., 13, 223-240.
17. Lebedeva I, Rando R, Ojwang J, Cossum P and Stein CA. (2000). Cancer Res., 60, 6052-6060.
18. Lebedeva IV, Su Z-Z, Chang Y, Kitada S, Reed JC and Fisher PB. (2002). Oncogene, 21, 708-718.
19. Lorenz M, Heinrich S, Staib-Sebler E, Kohne CH, Wils J, Nordlinger B and Encke A. (2000). Eur. J. Cancer, 36, 957-965.
20. Madireddi MT, Su ZZ, Young CSH, Goldstein NI and Fisher PB. (2000). Adv. Exp. Med. Biol., 465, 239-261.
21. Mhashilkar AM, Stewart AL, Sieger K, Yang HY, Khimani AH, Ito I, Saito Y, Hunt KK, Grimm EA, Roth JA, Meyn RE, Ramesh R and Chada S. (2003). Mol Ther., 8, 207-219.
22. Namiki S, Tomida T, Tanabe M, Iino M and Hirose K. (2003). Biochem. Biophys. Res. Commun., 305, 592-597.
23. Nemunitais J. (2003). Cancer Gene Therapy, 10, S106.
24. Parrish-Novak J, Xu W, Brender T, Yao L, Jones C, West J, Brandt C, Jelinek L, Madden K, McKernan PA, Foster DC, Jaspers S and Chandrasekher YA. (2002). J. Biol Chem., 277, 47517-47523.
25. Pestka S, Kotenko SV and Fisher PB. (2003). Encyclopedia of Homones. Henry HL, Norman AW (eds). Academic Press: San Diego, CA, pp. 507-513.
26. Pestka S, Krause CD, Sarkar D, Walter MR, Shi Y and Fisher PB. (2004). Annu. Rev. Immunol., 22, 929-979.
27. Ramesh R, Mhashilkar AM, Tanaka F, Saito Y, Branch CD, Sieger K, Mumm JB, Stewart AL, Boquio A, Dumoutier L, Grimm EA, Renauld JC, Kotenko S and Chada S. (2003). Cancer Res., 63, 5105-5113.
28. Regine WF, John WJ and Mohiuddin M. (1998). Front. Biosci., 3, E186-E192
29. Rosenberg L. (2000). Drugs, 59, 1071-1089.
30. Saeki T, Mhashilkar A, Chada S, Branch C, Roth JA and Ramesh R. (2000). Gene Ther., 7, 2051-2057.
31. Sarkar D, Su Z-Z, Lebedeva IV, Sauane M, Gopalkrishnan RV, Dent P and Fisher PB. (2002a). Biotechniques Oct. Suppl. 30-39.
32. Sarkar D, Su Z-Z, Lebedeva IV, Sauane M, Gopalkrishnan RV, Valerie K, Dent P and Fisher PB. (2002b). Proc. Natl. Acad. Sci. USA, 99, 10054-10059.
33. Sauane M, Gopalkrishnan RV, Lebedeva I, Mei MX, Sarkar D, Su Z-Z, Kang D-C, Dent P, Pestka S and Fisher PB. (2003a). J. Cell. Physiol, 196, 334-345.
34. Sauane M, Gopalkrishnan RV, Sarkar D, Su Z-Z, Lebedeva IV, Dent P, Pestka S and Fisher PB. (2003b). Cytokine Growth Factor Rev., 14, 35-51.
35. Sauane M, Lebedeva IV, Su Z-Z, Choo H-t, Randolph A, Valerie K, Dent P, Gopalkrishnan RV and Fisher PB. (2004). Cancer Res., 64, 2988-2993.
36. Sieger KA, Mhashilkar AM, Stewart A, Sutton RB, Strube RW, Chen SY, Pataer A, Swisher SG, Grimm EA, Ramesh R and Chada S. (2004). Mol Ther., 9, 355-367.
37. Smith DB and Johnson KS. (1988). Gene, 67, 31-40.
38. Spiotto MT and Chung TD. (2000). Prostate, 42, 88-98.
39. Su Z-Z, Lebedeva IV, Gopalkrishnan RV, Goldstein NI, Stein CA, Reed JC, Dent P and Fisher PB. (2001). Proc. Natl. Acad. Sci. USA, 98, 10332-10337.
40. Su Z-Z, Lebedeva IV, Sarkar D, Gopalkrishnan RV, Sauane M, Sigmon C, Yacoub A, Valerie K, Dent P and Fisher PB. (2003). Oncogene, 22, 1164-1180.
41. Su Z-Z, Madireddi MT, Lin JJ, Young CS, Kitada S, Reed JC, Goldstein NI and Fisher PB. (1998). Proc. Natl. Acad. Sci. USA, 95, 14400-14405.
42. Wang M, Tan Z, Zhang R, Kotenko SV and Liang P. (2002). J. Biol. Chem., 277, 7341-7347.
43. Yacoub A, Mitchell C, Brannon J, Rosenberg E, Qiao L, McKinstry R, Linehan WM, Su Z-Z, Sarkar D, Lebedeva IV, Valerie K, Gopalkrishnan RV, Grant S, Fisher PB and Dent P. (2003a). Mol. Cancer Ther., 2, 623-632.
44. Yacoub A, Mitchell C, Hong Y, Schroeder M, Gopalkrishnan RV, Su Z-Z, Gupta P, Sauane M, Lebedeva IV, Curiel DT, Mahasreshti PJ, Rosenfeld MR, Boraddus WC, James CD, Grant S, Fisher PB and Dent P. (2004). Cancer Biol. Ther. in press.
45. Yacoub A, Mitchell C, Lebedeva IV, Sarkar D, Su Z-Z, McKinstry R, Gopalkrishnan RV, Grant S, Fisher PB and Dent P. (2003b). Cancer Biol. Ther., 2, 347-353.
46. Zhan Y, Song X and Zhou GW. (2001). Gene, 281, 1-9.